Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent?

Y Karter1, A Curgunlu, S Altinişik

  • 1Department of Internal Medicine, Cerrahpaşa Medical Faculty, Istanbul University, Turkey. yesarikarter@yahoo.com

Blood Pressure
|February 7, 2004
PubMed

Insights

White coat hypertension (WCH) patients show intermediate target organ damage and cardiovascular risk between normotensive and sustained hypertensive individuals. These findings highlight WCH as a distinct clinical entity requiring further investigation for risk stratification.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Vascular Medicine

Background:

  • White coat hypertension (WCH) is characterized by elevated blood pressure in a clinical setting but normal readings outside of it.
  • Understanding the subclinical target organ damage and metabolic profile in WCH is crucial for cardiovascular risk assessment.

Purpose of the Study:

  • To comprehensively evaluate target organ status, metabolic abnormalities, and hemodynamic alterations in individuals with white coat hypertension.
  • To compare these parameters between normotensive (NT), WCH, and sustained hypertensive (HT) subjects.

Main Methods:

  • Inclusion of 50 NT, 90 WCH, and 101 HT subjects for extensive biochemical, echocardiographic, and fundoscopic examinations.
  • Subgroup analysis involving Doppler ultrasound to measure arterial compliance and intima-media thickness (IMT) of the left common carotid artery.
  • Assessment of body mass index (BMI), left ventricle mass index (LVMI), hypertensive retinopathy, urinary albumin excretion (UAE), total cholesterol, distensibility coefficient (DC), and compliance coefficient (CC).

Main Results:

  • WCH subjects exhibited higher BMI and LVMI compared to NTs, but lower than HTs.
  • Hypertensive retinopathy was present in WCH patients, though less severe and frequent than in HTs.
  • Arterial compliance (DC and CC) was reduced in WCH compared to NTs, while IMT was significantly higher in HTs than in both WCH and NTs.

Conclusions:

  • White coat hypertension patients represent an intermediate group concerning target organ damage and cardiovascular risk.
  • WCH is associated with metabolic and hemodynamic alterations, positioning it between normotension and sustained hypertension.
  • These findings underscore the importance of recognizing WCH as a distinct condition with potential long-term cardiovascular implications.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.